Huntsman Open New Polyetheramine Plant in Singapore

Huntsman Corporation formally opened its new world-scale JEFFAMINE® polyetheramine manufacturing facility at Jurong Island, Singapore. The plant, which was commissioned and began production in June, is the Company’s first production site in Singapore and will produce 16,000 tons of polyetheramines per year.

“From our vantage point as a leading polyetheramine producer for the U.S. and European markets for several decades, we were well-positioned to anticipate the growth potential for the product in the Asia Pacific region, especially in epoxy curatives and polyurea coatings,” said Peter Huntsman, President and CEO of Huntsman Corporation. “This new $40 million facility will be a key platform for us as we continue to support our customers’ global growth.”

Key JEFFAMINE® polyetheramine applications include epoxy coatings, concrete additives, organic pigments, fuel and lubricant additives, herbicides and pesticides. The new plant includes Huntsman’s latest proprietary amine technology to ensure safety and environmental performance.

Singapore was selected as the regional hub for Huntsman’s Performance Products division due to its favorable business environment, which offers strong intellectual property protection, a highly skilled workforce, excellent connectivity and a world class infrastructure.

“The Singapore plant, which complements Huntsman’s existing polyetheramine manufacturing facilities in Conroe, Texas, and Llanelli, Wales, gives us a truly global manufacturing footprint for polyetheramines, and provides a regional source for our customers with operations in the rapidly growing Asia Pacific market,” stated Don Stanutz, President of the Performance Products Division.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.